1.
Kockerols CC, Janssen JJ, Blijlevens NM, Klein SK, van Hussen-Daenen LG, van Gorkom GG, Smit WM, van Balen P, Biemond BJ, Cruijsen MJ, Corsten MF, te Boekhorst PA, Koene HR, van Sluis GL, Cornelissen JJ, Westerweel PE. Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population. haematol [Internet]. 2022Sep.8 [cited 2023Jan.28];108(1):240-4. Available from: https://haematologica.org/article/view/haematol.2022.281386